课题基金 / 基金详情

Elucidation of pathological role of NGAL as a modulator of kidney function, metabolism and immune system

Elucidation of pathological role of NGAL as a modulator of kidney function, metabolism and immune system
阐明 NGAL 作为肾功能、代谢和免疫系统调节剂的病理作用
批准号:
23390225
负责人:
MORI KIYOSHI
金额:
$12.4万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (B)
财政年份:
2011
资助国家:
日本
项目状态:
已结题
起止时间:
2011-04-01 至 2014-03-31

项目摘要

项目成果

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
NGAL KO mice exhibited worsening of adenine nephropathy. 80% of blood NGAL was derived from leukocytes, while urinary NGAL was mainly synthesized by the kidney. In chronic kidney disease, urinary NGAL was partly bound to polyIg receptor or a2-macroglobulin, and showed correlation with severity of renal pathologic changes. Under high fat diet, NGAL KO mice showed resistance against obesity. Hemodialysis patients having low blood NGAL levels showed increased risk to have malnutrition and to develop severe infection. Treatment of WT mice with LPS induced brain inflammation, reduced motor activity and recognition impairment, and these chnges were ameliorated in KO mice. NGAL expression was increased in BAL fluid and lung biopsy samples from patients with idiopathic pulmonary fibrosis.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
尿中バイオマーカーの新知見
尿液生物标志物的新发现
DOI: --
发表时间: 2011
期刊:
影响因子: --
作者: [森潔, 向山政志, 笠原正登, 横井秀基, 中尾一和]
通讯作者: 中尾一和
Acute disruption of megalin expression in renal cortex reveals compensatory reabsorption capacity of low molecular weight proteins in S3 segment of proximal tubules and collecting ducts
肾皮质巨蛋白表达的急性破坏揭示了近曲小管和集合管 S3 段低分子量蛋白的代偿性重吸收能力
DOI: --
发表时间:
期刊:
影响因子: --
作者: [KP Mori, K Mori (2nd), et al]
通讯作者: et al
Blockade of p38 MAPK pathway ameliorates aldosterone-induced renal injury in guanylyl cyclase-A deficient mice
阻断 p38 MAPK 通路可改善鸟苷酸环化酶 A 缺陷小鼠醛固酮诱导的肾损伤
DOI: --
发表时间: 2011
期刊:
影响因子: --
作者: [Kato Y, Mukoyama M, Yokoi H, et al.]
通讯作者: et al.
AKIと CKDのバイオマーカー
AKI 和 CKD 的生物标志物
DOI: --
发表时间: 2011
期刊:
影响因子: --
作者: [森潔, 向山政志, 笠原正登, 横井秀基, 桒原孝成, 中尾一和]
通讯作者: 中尾一和
44
    海外基金